TRPV1

• Cannabis hyperemesis syndrome: an update on the pathophysiology and management (16 Sep 2024)
  
• Expression of Cannabinoid Receptors in the Trigeminal Ganglion of the Horse (02 Sep 2024)
  
• Cannabinoid Analgesia in Postoperative Pain Management: From Molecular Mechanisms to Clinical Reality (02 Sep 2024)
  
• Expression of cannabinoid (CB1 and CB2) and cannabinoid-related receptors (TRPV1, GPR55, and PPARα) in the synovial membrane of the horse metacarpophalangeal joint (29 Aug 2024)
  
• Cannabinoid Compounds as a Pharmacotherapeutic Option for the Treatment of Non-Cancer Skin Diseases (28 Aug 2024)
  
• The Role of Cannabinoid Type 2 Receptors in Parkinson’s Disease (27 Aug 2024)
  
• The Enteric Glia and Its Modulation by the Endocannabinoid System, a New Target for Cannabinoid-Based Nutraceuticals? (27 Aug 2024)
  
• Cannabinoid receptors in the inflammatory cells of canine atopic dermatitis (27 Aug 2024)
  
• A Critical Evaluation of Terpenoid Signaling at Cannabinoid CB1 Receptors in a Neuronal Model (27 Aug 2024)
  
• The cannabinoid receptors system in horses: Tissue distribution and cellular identification in skin (25 Aug 2024)
  
• Distribution of Cannabinoid Receptors in Keratinocytes of Healthy Dogs and Dogs With Atopic Dermatitis (25 Aug 2024)
  
• Epigenetic Regulation of Cannabinoid-Mediated Attenuation of Inflammation and Its Impact on the Use of Cannabinoids to Treat Autoimmune Diseases (20 Aug 2024)
  
• Cannabinoid Therapeutics in Chronic Neuropathic Pain: From Animal Research to Human Treatment (20 Aug 2024)
  
• Cannabinoid Receptor 1 Inhibition in Chronic Kidney Disease: A New Therapeutic Toolbox (20 Aug 2024)
  
• Anti-inflammatory dopamine- and serotonin-based endocannabinoid epoxides reciprocally regulate cannabinoid receptors and the TRPV1 channel (20 Aug 2024)
  
• Cannabinoid Signaling in the Skin: Therapeutic Potential of the “C(ut)annabinoid” System (19 Aug 2024)
  
• Cannabinoid Ligands Targeting TRP Channels (19 Aug 2024)
  
• Allosteric Cannabinoid Receptor 1 (CB1) Ligands Reduce Ocular Pain and Inflammation (19 Aug 2024)
  
• Modulation of breast cancer cell viability by a cannabinoid receptor 2 (18 Aug 2024)
  
• Beyond Pain Relief: A Review on Cannabidiol Potential in Medical Therapies (27 Feb 2023)
  
• Major Phytocannabinoids and Their Related Compounds: Should We Only Search for Drugs That Act on Cannabinoid Receptors? (05 Sep 2022)
  
• A potential role for cannabichromene in modulating TRP channels during acute respiratory distress syndrome - Journal of Cannabis Research (05 Sep 2022)
  
• Minor Cannabinoids: Biosynthesis, Molecular Pharmacology and Potential Therapeutic Uses (01 Sep 2022)
  
• Reviewing the Role of the Endocannabinoid System in the Pathophysiology of Depression (27 Aug 2022)
  
• Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition (13 Aug 2022)
  
• Components of the Endocannabinoid System and Effects of Cannabinoids Against Bone Diseases: A Mini-Review (13 Aug 2022)
  
• The Mediterranean Diet as a Source of Bioactive Molecules with Cannabinomimetic Activity in Prevention and Therapy Strategy (07 Aug 2022)
  
• Targeting the Endocannabinoidome in Pancreatic Cancer (05 Aug 2022)
  
• Endocannabinoid-Mediated Control of Neural Circuit Excitability and Epileptic Seizures (05 Aug 2022)
  
• Chronic Pain and the Endocannabinoid System: Smart Lipids – A Novel Therapeutic Option? (05 Aug 2022)
  
• Endocannabinoid Modulation in Neurodegenerative Diseases: In Pursuit of Certainty (31 Jul 2022)
  
• Endocannabinoid System as a Promising Therapeutic Target in Inflammatory Bowel Disease – A Systematic Review (21 Jul 2022)
  
• Endocannabinoid Discovery Timeline (21 Jul 2022)
  
• CBD & Cannabis for Endometriosis (21 Jul 2022)
  
• What Is CBC Oil Good For? Benefits, Uses, & Effects (18 Jul 2022)